Trial Profile
A Prospective Observational Study on the Effect of Mepolizumab add-on Therapy on Daily Physical Activity in Patients With Severe Eosinophilic Asthma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2020
Price :
$35
*
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 16 Nov 2018 New trial record